Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mega Genomics Limited ( (HK:6667) ) has provided an update.
Mega Genomics Limited has announced a delay in the publication of its 2024 Annual Results due to unresolved issues related to revenue recognition from genetic testing kits and promotional activities. The company is working with its auditor to verify the rationale behind these transactions and may engage external parties for further investigation. An investigation committee has been established to address these issues, but the timeline and costs for the additional audit work are yet to be determined. Trading of the company’s stock remains suspended.
More about Mega Genomics Limited
YTD Price Performance: -34.43%
Average Trading Volume: 111,572
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.61B
See more data about 6667 stock on TipRanks’ Stock Analysis page.